![Paul Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Burgess
Corporate Officer/Principal bij
CEREVEL THERAPEUTICS HOLDINGS, INC.
Vermogen: - $ op 31-05-2026
Profiel
Paul Burgess is Chief Business Development Officer at Cerevel Therapeutics Holdings, Inc. since 2023 and Chief Operating & Business Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Director-Intellectual Property at Logical Therapeutics, Inc., In-House Counsel at Johnson & Johnson, Vice President-Intellectual Property at DNIB Unwind, Inc. from 2008 to 2015, Secretary, Chief Operating & Legal Officer at Translate Bio, Inc. from 2019 to 2021, Head-Intellectual Property at Civitas Therapeutics, Inc. from 2011 to 2015, Vice President-Intellectual Property at Scholar Rock, Inc. from 2015 to 2016, and Head-Legal at TransForm Pharmaceuticals, Inc. Education includes an undergraduate degree from Merrimack College in 1995 and graduate degrees from Northeastern University in 1999 and 2002.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 17-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Paul Burgess
| Bedrijven | Functie | Begin |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 20-06-2023 |
Eerdere bekende functies van Paul Burgess
| Bedrijven | Functie | Einde |
|---|---|---|
| TRANSLATE BIO, INC. | Operationeel Directeur | 14-09-2021 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01-04-2016 |
| DNIB UNWIND INC | Corporate Officer/Principal | 01-07-2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Corporate Officer/Principal | 01-02-2015 |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Algemeen Adviseur | - |
Opleiding van Paul Burgess
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
88
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Merrimack College
 Merrimack College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Kies MarketScreener 
